2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Breast
1
Conditions
Breast Neoplasms
2
Ventricular Dysfunction, Left
1
Lymphoma, Large B-Cell, Diffuse
1
Cardiotoxicity
1
Interventions
Nebivolol
1
Methods
1
Exercise Therapy
1
Exercise
1
Electrocardiography
1
Echocardiography
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ventricular Dysfunction, Left
×
Nebivolol
×
Clear all
NCT05728632
2023-02-23
CONTROL
Humanitas Hospital, Italy
Phase 3
Unknown
80 enrolled